Dermatology (26 companies · 13 conditions)

Conditions

Atopic Dermatitis 13 Psoriasis 5 Hidradenitis Suppurativa 4 Rare Alopecia Areata 2 Lymphatic Malformation 2 Rare Onychomycosis 2 Pemphigus 2 Rare Acne 1 Androgenetic Alopecia 1 Lichen Planus 1 Prurigo Nodularis 1 Rosacea 1 Vitiligo 1

Companies

Ticker	Company	Therapeutic areas	In Dermatology	Lead stage	Programs
ABSI	Absci	DermatologyGI/Hepatology+1	1	Phase 1	7
ACRS	Aclaris Therapeutics	DermatologyRespiratory	5	Phase 2	7
ALDX	Aldeyra Therapeutics	DermatologyOncology+1 Rare	1	NDA Submitted	8
ANAB	AnaptysBio	DermatologyGI/Hepatology+2 Rare	1	Approved	6
APGE	Apogee Therapeutics	DermatologyGI/Hepatology+1 Rare	2	Phase 2	9
RCUS	Arcus Biosciences	DermatologyImmunology+1	1	Phase 3	6
ARTV	Artiva Biotherapeutics	DermatologyImmunology+2 Rare	1	Phase 2	16
CABA	Cabaletta Bio	DermatologyImmunology+2 Rare	1	Phase 1	8
CLDX	Celldex Therapeutics	DermatologyImmunology+1	2	Phase 3	7
CRVS	Corvus Pharmaceuticals	DermatologyOncology	1	Phase 3	4
ENTA	Enanta Pharmaceuticals	DermatologyImmunology+1	1	Phase 3	6
EVMN	Evommune	DermatologyImmunology+1	2	Phase 2	6
FBRX	Forte Biosciences	DermatologyGI/Hepatology	2	Phase 2	3
FBIO	Fortress Biotech	DermatologyHematology+1 Rare	1	Approved	12
KYMR	Kymera Therapeutics	DermatologyRespiratory Rare	2	Phase 2	4
GLUE	Monte Rosa Therapeutics	CardiovascularDermatology+2 Rare	1	Phase 1	8
NKTR	Nektar Therapeutics	DermatologyImmunology+2	2	Phase 2	11
ORKA	Oruka Therapeutics	DermatologyImmunology Rare	4	Phase 2	6
TARA	Protara Therapeutics	DermatologyMetabolic+1 Rare	1	Phase 3	3
QNRX	Quoin Pharmaceuticals	DermatologyImmunology Rare	1	Phase 2	8
RVPH	Reviva Pharmaceuticals	CardiovascularDermatology+2 Rare	1	Phase 3	10
SGMT	Sagimet Biosciences	DermatologyMetabolic	3	Phase 3	5
TTRX	Turn Therapeutics	DermatologyInfectious Disease	3	Phase 3	4
VNDA	Vanda Pharmaceuticals	CardiovascularDermatology+6 Rare	4	Approved	26
ZBIO	Zenas BioPharma	DermatologyImmunology+1 Rare	1	NDA Submitted	11
ZURA	Zura Bio	DermatologyImmunology Rare	2	Phase 2	4